- Report
- September 2025
- 83 Pages
Azerbaijan
From €2675EUR$3,228USD£2,414GBP
From €2675EUR$3,228USD£2,414GBP
- Report
- September 2025
- 52 Pages
Angola
From €2150EUR$2,595USD£1,940GBP
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,201USD£898GBP
- Report
- April 2025
- 130 Pages
Brazil
From €2675EUR$3,228USD£2,414GBP
- Report
- January 2025
- 24 Pages
Singapore
From €995EUR$1,201USD£898GBP
- Report
- January 2025
- 109 Pages
Singapore
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 23 Pages
Indonesia
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 99 Pages
Indonesia
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 22 Pages
North Macedonia
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 80 Pages
North Macedonia
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 77 Pages
Tunisia
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 23 Pages
Kenya
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 24 Pages
South Africa
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,201USD£898GBP
- Report
- October 2024
- 75 Pages
Uzbekistan
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 84 Pages
Kenya
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 107 Pages
Ukraine
From €2675EUR$3,228USD£2,414GBP
- Report
- October 2024
- 64 Pages
Myanmar
From €2150EUR$2,595USD£1,940GBP

Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more